Trial
NCT04855201
A Study to Evaluate ASP0367 in Participants With Reduced Maximum Oxygen Uptake Due to Poor Systemic Oxygen Extraction
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Astellas Pharma Global Development, Inc.
Collaborators
—
Condition
Reduced Maximum Oxygen Uptake Due to Poor Systemic Oxygen Extraction
Intervention
Bocidelpar
Why stopped
Lack of Pharmacological effect
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-04-16